•
Dec 31, 2020

Edgewise Therapeutics Q4 2020 Earnings Report

EPS
-$23.2
Cash and Equivalents
$105M
Free Cash Flow
-$4.64M
Total Assets
$131M

Edgewise Therapeutics

Edgewise Therapeutics